Nonalcoholic fatty liver disease and cardiovascular disease: Has the time come for cardiologists to be hepatologists?

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Ahmed, Mohamed H ^a   Barakat, Salma ^b   Almobarak, Ahmed O ^c  

^a WEXHAM PARK HOSPITAL   (United Kingdom)

^b FEDERAL MINISTRY OF HEALTH   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ARTERIAL WALL THICKNESS; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PHYSICIAN; REVIEW; CAROTID ARTERY DISEASE; FATTY LIVER; RISK FACTOR; SLEEP DISORDERED BREATHING;

CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; COMORBIDITY; FATTY LIVER; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

MLCS; MLOWN;

EID: 84872765906     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/483135     Document Type: Review

References (94)

1. Ahmed M. H., Byrne C. D., Obstructive sleep apnea syndrome and fatty liver: association or causal link? World Journal of Gastroenterology 2010 16 34 4243 4252 2-s2.0-77957569174 10.3748/wjg.v16.i34.4243
2. Ahmed M. H., Byrne C. D., Byrne C., Wild S., Non alcoholic steatatohepatitis and metabolic syndrome. Metabolic Syndrome 2005 Chichester, UK John Wiley & Sons 279 305
3. Browning J. D., Szczepaniak L. S., Dobbins R., Nuremberg P., Horton J. D., Cohen J. C., Grundy S. M., Hobbs H. H., Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 6 1387 1395 2-s2.0-10644220306 10.1002/hep.20466 (Pubitemid 39657013)
4. Szczepaniak L. S., Nurenberg P., Leonard D., Browning J. D., Reingold J. S., Grundy S., Hobbs H. H., Dobbins R. L., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology 2005 288 2 E462 E468 2-s2.0-12144259379 10.1152/ajpendo.00064.2004 (Pubitemid 40110657)
5. Bellentani S., Saccoccio G., Masutti F., Crocè L. S., Brandi G., Sasso F., Cristanini G., Tiribelli C., Prevalence of and risk factors for hepatic steatosis in Northern Italy. Annals of Internal Medicine 2000 132 2 112 117 2-s2.0-0033982172 (Pubitemid 30044177)
6. Liu B., Balkwill A., Reeves G., Beral V., Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. British Medical Journal 2010 340, article c912 2-s2.0-77949905447 10.1136/bmj.c912
7. Hart C. L., Morrison D. S., Batty G. D., Mitchell R. J., Davey Smith G., Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. British Medical Journal 2010 340, article c1240 2-s2.0-77949911808 10.1136/bmj.c1240
8. Ahmed M. H., Byrne C. D., Packard C. J., Metabolic syndrome, diabetes & CHD risk. The Year in Lipid Disorders 2007 Oxford, UK Clinical Publishing 3 26
9. Kim H. J., Kim H. J., Lee K. E., Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Archives of Internal Medicine 2004 164 19 2169 2175 2-s2.0-6944227798 10.1001/archinte.164.19.2169 (Pubitemid 39410808)
10. Dixon J. B., Bhathal P. S., O'Brien P. E., Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001 121 1 91 100 2-s2.0-0034950652 (Pubitemid 32591518)
11. Akbar D. H., Kawther A. H., Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care 2003 26 12 3351 3352 2-s2.0-0344412841 10.2337/diacare.26.12.3351
12. Kojima S. I., Watanabe N., Numata M., Ogawa T., Matsuzaki S., Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. Journal of Gastroenterology 2003 38 10 954 961 2-s2.0-0344393668 10.1007/s00535-003-1178-8 (Pubitemid 37455782)
13. Fan J. G., Zhu J., Li X. J., Chen L., Lu Y. S., Li L., Dai F., Li F., Chen S. Y., Fatty liver and the metabolic syndrome among Shanghai adults. Journal of Gastroenterology and Hepatology 2005 20 12 1825 1832 2-s2.0-33644878193 10.1111/j.1440-1746.2005.04058.x (Pubitemid 43961036)
14. Fan J. G., Zhu J., Li X. J., Chen L., Li L., Dai F., Li F., Chen S. Y., Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology 2005 43 3 508 514 2-s2.0-23444451889 10.1016/j.jhep.2005.02.042 (Pubitemid 41111434)
15. Schwimmer J. B., Deutsch R., Kahen T., Lavine J. E., Stanley C., Behling C., Prevalence of fatty liver in children and adolescents. Pediatrics 2006 118 4 1388 1393 2-s2.0-33750002388 10.1542/peds.2006-1212 (Pubitemid 46393782)
16. Radetti G., Kleon W., Stuefer J., Pittschieler K., Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatrica 2006 95 7 833 837 2-s2.0-33747596229 10.1080/08035250500449890 (Pubitemid 44261742)
17. Ahmed M. H., Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease. American Journal of Clinical Pathology 2007 127 1 20 22 2-s2.0-34249053560 10.1309/JXWUM661T8VT1ETX (Pubitemid 46797013)
18. Adams L. A., Harmsen S., St Sauver J. L., Charatcharoenwitthaya P., Enders F. B., Therneau T., Angulo P., Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. American Journal of Gastroenterology 2010 105 7 1567 1573 2-s2.0-77954424925 10.1038/ajg.2010.18
19. Chiang P. H., Chang T. Y., Chen J. D., Synergistic effect of fatty liver and smoking on metabolic syndrome. World Journal of Gastroenterology 2009 15 42 5334 5339 2-s2.0-74249109801 10.3748/wjg.15.5334
20. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation 2009 120 16 1640 1645 2-s2.0-70350245011 10.1161/CIRCULATIONAHA.109.192644
21. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S., Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology 2005 42 1 44 52 2-s2.0-21344449292 10.1002/hep.20734 (Pubitemid 40911310)
22. Rocha R., Cotrim H. P., Carvalho F. M., Siqueira A. C., Braga H., Freitas L. A., Body mass index and waist circumference in non-alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics 2005 18 5 365 370 2-s2.0-25844516372 10.1111/j.1365-277X.2005.00634.x (Pubitemid 41387905)
23. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., Cassader M., David E., Cavallo-Perin P., Rizzetto M., Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002 35 2 367 372 2-s2.0-18244385511 10.1053/jhep.2002.30690 (Pubitemid 34106376)
24. Rocha R., Cotrim H. P., Carvalho F. M., Siqueira A. C., Braga H., Freitas L. A., Body mass index and waist circumference in non-alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics 2005 18 5 365 370 (Pubitemid 41387905)
25. Chitturi S., Abeygunasekera S., Farrell G. C., Holmes-Walker J., Hui J. M., Fung C., Karim R., Lin R., Samarasinghe D., Liddle C., Weltman M., George J., NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002 35 2 373 379 2-s2.0-18244364864 10.1053/jhep.2002.30692 (Pubitemid 34106377)
26. Gastaldelli A., Kozakova M., Höjlund K., Flyvbjerg A., Favuzzi A., Mitrakou A., Balkau B., Heine R. J., Dekker J., Nijpels G., Boorsma W., Tournis S., Kyriakopoulou K., Thomakos P., Lalic N., Lalic K., Jotic A., Lukic L., Civcic M., Nolan J., Yeow T. P., Murphy M., DeLong C., Neary G., Colgan M. P., Hatunic M., Konrad T., Bohles H., Fuellert S., Baer F., Zuchhold H., Golay A., Harsch Bobbioni E., Barthassat V., Makoundou V., Lehmann T. N. O., Merminod T., Petrie J. R., Perry C., Neary F., MacDougall C., Shields K., Malcolm L., Laakso M., Salmenniemi U., Aura A., Raisanen R., Ruotsalainen U., Sistonen T., Laitinen M., Saloranta H., Coppack S. W., McIntosh N., Khadobaksh P., Laville M., Bonnet F., Brac de la Perriere A., Louche-Pelissier C., Maitrepierre C., Peyrat J., Serusclat A., Gabriel R., Sańchez E. M., Carraro R., Friera A., Novella B., Nilsson P., Persson M., OÖstling G., Melander O., Burri P., Piatti P. M., Monti L. D., Setola E., Galluccio E., Minicucci F., Colleluori A., Walker M., Ibrahim I. M., Jayapaul M., Carman D., Short K., McGrady Y., Richardson D., Beck-Nielsen H., Staehr P., Hojlund K., Vestergaard V., Olsen C., Hansen L., Bolli G. B., Porcellati F., Fanelli C., Lucidi P., Calcinaro F., Saturni A., Ferrannini E., Natali A., Muscelli E., Pinnola S., Kozakova M., Mingrone G., Guidone C., Favuzzi A., Di Rocco P., Anderwald C., Bischof M., Promintzer M., Krebs M., Mandl M., Hofer A., Luger A., Waldhaäusl W., Roden M., Coppack S. W., Dekker J. M., Mari A., Walker M., Gaffney P., Boran G., Kok A., Dekker J., Patel S., Ciociaro D., Guillanneuf M. T., Mhamdi L., Pacini G., Cavaggion C., Hills S. A., Landucci L., Mota L., Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009 49 5 1537 1544 2-s2.0-66149119340 10.1002/hep.22845
27. Dam-Larsen S., Becker U., Franzmann M. B., Larsen K., Christoffersen P., Bendtsen F., Final results of a long-term, clinical follow-up in fatty liver patients. Scandinavian Journal of Gastroenterology 2009 44 10 1236 1243 2-s2.0-70350626532 10.1080/00365520903171284
28. Alkhouri N., Tamimi T. A. R., Yerian L., Lopez R., Zein N. N., Feldstein A. E., The inflamed liver and atherosclerosis: a Link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Digestive Diseases and Sciences 2010 55 9 2644 2650 2-s2.0-77956189968 10.1007/s10620-009-1075-y
29. Domanski J. P., Park S. J., Harrison S. A., Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter? Journal of Clinical Gastroenterology 2012 46 5 427 430
30. Ramilli S., Pretolani S., Muscari A., Pacelli B., Arienti V., Carotid lesions in outpatients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2009 15 38 4770 4774 2-s2.0-73449106425 10.3748/wjg.15.4770
31. McCullough A. J., The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clinics in Liver Disease 2004 8 3 521 533 2-s2.0-4344628555 10.1016/j.cld.2004.04.004 (Pubitemid 39141140)
32. Tolman K. G., Fonseca V., Tan M. H., Dalpiaz A., Narrative review: hepatobiliary disease in type 2 diabetes mellitus. Annals of Internal Medicine 2004 141 12 946 956 2-s2.0-11144307888 (Pubitemid 40040978)
33. Jousilahti P., Rastenyte D., Tuomilehto J., Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000 31 8 1851 1855 2-s2.0-0033853134 (Pubitemid 30620462)
34. Wannamethee G., Ebrahim S., Shaper A. G., Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. American Journal of Epidemiology 1995 142 7 699 708 2-s2.0-0029086625
35. Kozakova M., Palombo C., Paterni M., Fatty liver index, gamma-glutamyltransferase and early carotid plaques. Hepatology 2012 55 5 1406 1415
36. Schindhelm R. K., Dekker J. M., Nijpels G., Bouter L. M., Stehouwer C. D. A., Heine R. J., Diamant M., Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007 191 2 391 396 2-s2.0-33947169979 10.1016/j.atherosclerosis.2006.04.006 (Pubitemid 46400701)
37. Wang C. C., Lin S. K., Tseng Y. F., Hsu C. S., Tseng T. C., Lin H. H., Wang L. Y., Kao J. H., Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2009 24 8 1411 1416 2-s2.0-69049111026 10.1111/j.1440-1746.2009.05872.x
38. Ioannou G. N., Weiss N. S., Boyko E. J., Mozaffarian D., Lee S. P., Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006 43 5 1145 1151 2-s2.0-33646547644 10.1002/hep.21171 (Pubitemid 43724639)
39. Monami M., Bardini G., Lamanna C., Pala L., Cresci B., Francesconi P., Buiatti E., Rotella C. M., Mannucci E., Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008 57 3 387 392 2-s2.0-38749102436 10.1016/j.metabol.2007.10.015 (Pubitemid 351178729)
40. Lopez-Suarez A., Guerrero J. M., Elvira-Gonzalez J., Beltran-Robles M., Canas-Hormigo F., Bascunana-Quirell A., Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. European Journal of Gastroenterology and Hepatology 2011 23 11 1011 1017
41. Lazo M., Hernaez R., Bonekamp S., Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. British Medical Journal 2011 343, article d6891
42. Stepanova M., Younossi Z. M., Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clinical Gastroenterology and Hepatology 2012 10 6 646 650
43. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007 30 5 1212 1218 2-s2.0-34247605492 10.2337/dc06-2247 (Pubitemid 46684650)
44. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., Zenari L., Falezza G., Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005 54 12 3541 3546 2-s2.0-33644700376 10.2337/diabetes.54.12.3541 (Pubitemid 43334347)
45. Pacifico L., Cantisani V., Ricci P., Osborn J. F., Schiavo E., Anania C., Ferrara E., Dvisic G., Chiesa C., Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatric Research 2008 63 4 423 427 2-s2.0-41349113441 10.1203/PDR.0b013e318165b8e7 (Pubitemid 351450591)
46. Schwimmer J. B., Pardee P. E., Lavine J. E., Blumkin A. K., Cook S., Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008 118 3 277 283 2-s2.0-49149114288 10.1161/CIRCULATIONAHA.107.739920
47. Fracanzani A. L., Burdick L., Raselli S., Pedotti P., Grigore L., Santorelli G., Valenti L., Maraschi A., Catapano A., Fargion S., Carotid artery intima-media thickness in nonalcoholic fatty liver disease. American Journal of Medicine 2008 121 1 72 78 2-s2.0-37649012018 10.1016/j.amjmed.2007.08.041
48. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Zenari L., Cigolini M., Falezza G., Arcaro G., Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006 29 6 1325 1330 2-s2.0-33746421488 10.2337/dc06-0135 (Pubitemid 44125930)
49. Völzke H., Robinson D. M., Kleine V., Deutscher R., Hoffmann W., Lüdemann J., Schminke U., Kessler C., John U., Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World Journal of Gastroenterology 2005 11 12 1848 1853 2-s2.0-17144387889 (Pubitemid 40520783)
50. Petit J. M., Guiu B., Terriat B., Loffroy R., Robin I., Petit V., Bouillet B., Brindisi M. C., Duvillard L., Hillon P., Cercueil J. P., Verges B., Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2009 94 10 4103 4106 2-s2.0-70349906752 10.1210/jc.2009-0541
51. Kim H. C., Kim D. J., Huh K. B., Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009 204 2 521 525 2-s2.0-67349209088 10.1016/j.atherosclerosis.2008.09.012
52. Schindhelm R. K., Diamant M., Bakker S. J. L., Van Dijk R. A. J. M., Scheffer P. G., Teerlink T., Kostense P. J., Heine R. J., Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. European Journal of Clinical Investigation 2005 35 6 369 374 2-s2.0-20444455921 10.1111/j.1365-2362.2005.01502.x (Pubitemid 40826835)
53. Villanova N., Moscatiello S., Ramilli S., Bugianesi E., Magalotti D., Vanni E., Zoli M., Marchesini G., Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005 42 2 473 480 2-s2.0-23044512117 10.1002/hep.20781 (Pubitemid 41061101)
54. Samuel V. T., Liu Z. X., Qu X., Elder B. D., Bilz S., Befroy D., Romanelli A. J., Shulman G. I., Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Biological Chemistry 2004 279 31 32345 32353 2-s2.0-3543029821 10.1074/jbc.M313478200 (Pubitemid 39014687)
55. Cai D., Yuan M., Frantz D. F., Melendez P. A., Hansen L., Lee J., Shoelson S. E., Local and systemic insulin resistance resulting from hepatic activation of IKK- β and NF- B. Nature Medicine 2005 11 2 183 190 2-s2.0-14644427890 10.1038/nm1166 (Pubitemid 40321354)
56. Musso G., Gambino R., De Michieli F., Durazzo M., Pagano G., Cassader M., Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH. Hepatology 2008 47 4 1167 1177 2-s2.0-42249084876 10.1002/hep.22142 (Pubitemid 351547903)
57. Pagano C., Soardo G., Esposito W., Fallo F., Basan L., Donnini D., Federspil G., Sechi L. A., Vettor R., Plasma adiponectin is decreased in nonalcoholic fatty liver disease. European Journal of Endocrinology 2005 152 1 113 118 2-s2.0-13244295710 10.1530/eje.1.01821 (Pubitemid 40185459)
58. Targher G., Bertolini L., Scala L., Poli F., Zenari L., Falezza G., Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clinical Endocrinology 2004 61 6 700 703 2-s2.0-10844246291 10.1111/j.1365-2265.2004.02151.x (Pubitemid 40006789)
59. Pischon T., Girman C. J., Hotamisligil G. S., Rifai N., Hu F. B., Rimm E. B., Plasma adiponectin levels and risk of myocardial infarction in Men. Journal of the American Medical Association 2004 291 14 1730 1737 2-s2.0-1842864234 10.1001/jama.291.14.1730 (Pubitemid 38489895)
60. Matikainen N., Mänttäri S., Westerbacka J., Vehkavaara S., Lundbom N., Yki-Järvinen H., Taskinen M. R., Postprandial lipemia associates with liver fat content. Journal of Clinical Endocrinology and Metabolism 2007 92 8 3052 3059 2-s2.0-34547750961 10.1210/jc.2007-0187 (Pubitemid 47236370)
61. Basciano H., Miller A. E., Naples M., Baker C., Kohen R., Xu E., Su Q., Allister E. M., Wheeler M. B., Adeli K., Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. American Journal of Physiology 2009 297 2 E462 E473 2-s2.0-68049099023 10.1152/ajpendo.90764.2008
62. Hadaegh F., Harati H., Ghanbarian A., Azizi F., Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. Eastern Mediterranean Health Journal 2009 15 1 157 166 2-s2.0-67649864061
63. Nordestgaard B. G., Benn M., Schnohr P., Tybjaerg-Hansen A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Journal of the American Medical Association 2007 298 3 299 308 (Pubitemid 47080484)
64. Bansal S., Buring J. E., Rifai N., Mora S., Sacks F. M., Ridker P. M., Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of the American Medical Association 2007 298 3 309 316 2-s2.0-34447520136 10.1001/jama.298.3.309 (Pubitemid 47080485)
65. Freiberg J. J., Tybjærg-Hansen A., Jensen J. S., Nordestgaard B. G., Nonfasting triglycerides and risk of ischemic stroke in the general population. Journal of the American Medical Association 2008 300 18 2142 2152 2-s2.0-56149115017 10.1001/jama.2008.621
66. Mora S., Rifai N., Buring J. E., Ridker P. M., Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008 118 10 993 1001 2-s2.0-52149109922 10.1161/ CIRCULATIONAHA.108.777334
67. Kim D., Choi S. Y., Park E. H., Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012 56 2 605 613
68. Yilmaz Y., Kurt R., Yonal O., Polat N., Celikel C. A., Gurdal A., Oflaz H., Ozdogan O., Imeryuz N., Kalayci C., Avsar E., Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis 2010 211 1 182 186 2-s2.0-77954315951 10.1016/j.atherosclerosis.2010.01.049
69. Goland S., Shimoni S., Zornitzki T., Knobler H., Azoulai O., Lutaty G., Melzer E., Orr A., Caspi A., Malnick S., Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. Journal of Clinical Gastroenterology 2006 40 10 949 955 2-s2.0-33750630075 10.1097/01.mcg.0000225668.53673.e6 (Pubitemid 44690772)
70. Bonapace S., Perseghin G., Molon G., Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012 35 2 389 395
71. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S., The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine 1993 328 17 1230 1235 2-s2.0-0027462562 10.1056/NEJM199304293281704 (Pubitemid 23115702)
72. Flemons W. W., Buysse D., Redline S., Oack A., Strohl K., Wheatley J., Young T., Douglas N., Levy P., McNicolas W., Fleetham J., White D., Schmidt-Nowarra W., Carley D., Romaniuk J., Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999 22 5 667 689 2-s2.0-0033178851 (Pubitemid 29379124)
73. Byrne C. D., Hypoxia and non-alcoholic fatty liver disease. Clinical Science 2010 118 6 397 400 2-s2.0-73149109067 10.1042/CS20090565
74. Nishibayashi M., Miyamoto M., Miyamoto T., Suzuki K., Hirata K., Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. Journal of Clinical Sleep Medicine 2008 4 3 242 247 2-s2.0-47849131844 (Pubitemid 352039435)
75. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., Tkacova R., Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008 134 4 686 692 2-s2.0-54249085473 10.1378/chest.08-0556
76. Takama N., Kurabayashi M., Influence of untreated sleep-disordered breathing on the long-term prognosis of patients with cardiovascular disease. American Journal of Cardiology 2009 103 5 730 734 2-s2.0-60249099568 10.1016/j.amjcard.2008.10.035
77. Savransky V., Nanayakkara A., Vivero A., Li J., Bevans S., Smith P. L., Torbenson M. S., Polotsky V. Y., Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007 45 4 1007 1013 2-s2.0-34247359442 10.1002/hep.21593 (Pubitemid 46631569)
78. Savransky V., Bevans S., Nanayakkara A., Li J., Smith P. L., Torbenson M. S., Polotsky V. Y., Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. American Journal of Physiology 2007 293 4 G871 G877 2-s2.0-35349013538 10.1152/ajpgi.00145.2007 (Pubitemid 47605939)
79. Takayama F., Egashira T., Kawasaki H., Mankura M., Nakamoto K., Okada S., Mori A., A novel animal model of nonalcoholic steatohepatitis (NASH): hypoxemia enhances the development of NASH. Journal of Clinical Biochemistry and Nutrition 2009 45 3 335 340 2-s2.0-70549105135 10.3164/jcbn.09-29
80. Piguet A. C., Stroka D., Zimmermann A., Dufour J. F., Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical Science 2010 118 6 401 410 2-s2.0-73149083947 10.1042/CS20090313
81. Bradley T. D., Floras J. S., Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 2009 373 9657 82 93 2-s2.0-58049158570 10.1016/S0140-6736(08)61622-0
82. Fletcher E. C., DeBehnke R. D., Lovoi M. S., Gorin A. B., Undiagnosed sleep apnea in patients with essential hypertension. Annals of Internal Medicine 1985 103 2 190 195 2-s2.0-0021792721 (Pubitemid 15000567)
83. Logan A. G., Perlikowski S. M., Mente A., Tisler A., Tkacova R., Niroumand M., Leung R. S. T., Bradley T. D., High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. Journal of Hypertension 2001 19 12 2271 2277 2-s2.0-0035215206 10.1097/00004872-200112000-00022 (Pubitemid 33135251)
84. Börgel J., Sanner B. M., Keskin F., Bittlinsky A., Karen Bartels N., Büchner N., Huesing A., Christian Rump L., Mügge A., Obstructive sleep apnea and blood pressure: interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. American Journal of Hypertension 2004 17 12 1081 1087 2-s2.0-11144330059 10.1016/j.amjhyper.2004.06.026 (Pubitemid 40029403)
85. Peker Y., Kraiczi H., Hedner J., Löth S., Johansson A., Bende M., An independent association between obstructive sleep apnoea and coronary artery disease. European Respiratory Journal 1999 14 1 179 184 2-s2.0-0032866064 10.1034/j.1399-3003.1999.14a30.x (Pubitemid 29411254)
86. Mooe T., Franklin K. A., Holmström K., Rabben T., Wiklund U., Sleep-disordered breathing and coronary artery disease: long-term prognosis. American Journal of Respiratory and Critical Care Medicine 2001 164 10 1910 1913 2-s2.0-0035891601 (Pubitemid 33152329)
87. Good D. C., Henkle J. Q., Gelber D., Welsh J., Verhulst S., Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996 27 2 252 259 2-s2.0-0030050391 (Pubitemid 26044496)
88. Kaneko Y., Hajek V. E., Zivanovic V., Raboud J., Bradley T. D., Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003 26 3 293 297 2-s2.0-0042853169 (Pubitemid 39610676)
89. Targher G., Bertolini L., Rodella S., Zoppini G., Lippi G., Day C., Muggeo M., Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008 51 3 444 450 2-s2.0-39049102073 10.1007/s00125-007-0897-4
90. Targher G., Chonchol M., Bertolini L., Rodella S., Zenari L., Lippi G., Franchini M., Zoppini G., Muggeo M., Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. Journal of the American Society of Nephrology 2008 19 8 1564 1570 2-s2.0-49649090452 10.1681/ASN.2007101155
91. Chang Y., Ryu S., Sung E., Woo H. Y., Oh E., Cha K., Jung E., Kim W. S., Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008 57 4 569 576 2-s2.0-40049095342 10.1016/j.metabol.2007.11.022 (Pubitemid 351320606)
92. Chalasani N., Younossi Z., Lavine J. E., The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012 55 6 2005 2023
93. Cohen D. E., Anania F. A., Chalasani N., An assessment of statin safety by hepatologists. American Journal of Cardiology 2006 97 8 S77 S81 2-s2.0-33645888317 10.1016/j.amjcard.2005.12.014
94. Ahmed M. H., Byrne C. D., Current treatment of non-alcoholic fatty liver disease. Diabetes, Obesity and Metabolism 2009 11 3 188 195 2-s2.0-59349107500 10.1111/j.1463-1326.2008.00926.x